• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merus N.V. - Common Shares (NQ:MRUS)

90.00 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merus N.V. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Merus Appoints Life Sciences Strategic and Financial Industry Veteran Greg Perry as Chief Financial Officer
June 15, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference 2023
May 31, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
7 Stocks That Wall Street Analysts Are Loving in May ↗
May 21, 2023
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love. 
Via InvestorPlace
News headline image
Where Merus Stands With Analysts ↗
May 18, 2023
 
Via Benzinga
News headline image
Recap: Merus Q1 Earnings ↗
May 04, 2023
 
Via Benzinga
News headline image
Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy ↗
April 18, 2023
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Merus ↗
April 05, 2023
 
Via Benzinga
News headline image
Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
May 04, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
April 18, 2023
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... 
Via Benzinga
News headline image
4 Analysts Have This to Say About Merus ↗
March 01, 2023
 
Via Benzinga
Merus Earnings Perspective: Return On Capital Employed ↗
November 24, 2022
 
Via Benzinga
News headline image
5 Analysts Have This to Say About Merus ↗
November 16, 2022
 
Via Benzinga
News headline image
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗
April 18, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Merus’ Petosemtamab Interim Data Demonstrates Clinically Meaningful Activity in Previously Treated Head and Neck Squamous Cell Carcinoma (HNSCC)
April 17, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst ↗
April 14, 2023
 
Via Benzinga
News headline image
Merus Announces Publication of an Abstract on Petosemtamab in Advanced Gastric/Esophageal Adenocarcinoma for Presentation at the AACR Annual Meeting 2023
April 14, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2023 and Provides a Program and Regulatory Update
April 14, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
What To Expect When Merus Presents Petosemtamab Data Update At AACR ↗
April 06, 2023
 
Via Benzinga
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Merus Announces Publication of an Abstract on Preclinical Mechanism of Action of MCLA-129 Selected for Poster Presentation at the AACR Annual Meeting 2023
March 14, 2023
Poster presentation: Tuesday, April 18, 2023, 1:30-5:30 p.m. ET 
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Announces Petosemtamab in Previously Treated Head and Neck Squamous Cell Carcinoma Abstract Selected for Plenary Session Oral Presentation at the AACR Annual Meeting 2023
March 14, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Announces Financial Results for the Fourth Quarter and Full Year 2022 and Provides Business Update
February 28, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday ↗
February 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
February 09, 2023
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. 
Via Benzinga
News headline image
Merus to Participate in Upcoming Investor Conferences
February 01, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
CORRECTING and REPLACING --Merus Provides 2023 Outlook
January 09, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Provides 2023 Outlook
January 08, 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
November 09, 2022
From Merus N.V.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗
January 05, 2023
 
Via Benzinga
News headline image
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗
November 04, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap